热门资讯> 正文
CGC、KNDI和ESPR均为市前涨幅股
2024-03-25 19:55
- Gainers: MicroAlgo (MLGO) +51%.
- Flora Growth (FLGC) +30%.
- Esperion Therapeutics (ESPR) +21%.
- Moleculin Biotech (MBRX) +19% Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML Trial.
- Nkarta (NKTX) +17% announces pricing of stock offering to raise $240.1M.
- Forge Global Holdings (FRGE) +16%.
- Canopy Growth Corporation (CGC) +11%.
- Axsome Therapeutics (AXSM) +9% Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients.
- Solowin Holdings (SWIN) +7%.
- Digital World Acquisition (DWAC) +6%.
- Aemetis (AMTX) +6%.
- Inspira Technologies Oxy (IINN) +6%.
- NKGen Biotech (NKGN) +6%.
- Cronos Group (CRON) +5% Launches Lord Jones Chocolate Fusions
- WM Technology (MAPS) +5%.
- Kandi Technologies Group (KNDI) +5%.
More on premarket gainers & stock
- Canopy Growth Is Climbing, But It Won't Last
- Kandi Technologies Group, Inc. (KNDI) Q4 2023 Earnings Call Transcript
- A Relief Earnings Report Ahead Of An Inflection Point For Esperion Therapeutics
- Cannabis stocks rally as Schumer circulates petition for SAFER Banking Act
- Cannabis stocks rally for second session in a row, led by Canopy Growth
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
